$0.3567
0.01674.91%
Last update: Jul 15, 9:47 AM
Trinity Biotech PLC Stock Guidance
TRIBNASDAQ
Trinity Biotech (TRIB) last issued guidance on March 10, 2026 for Q4 2025. The company guided revenue in the range of $11.50M - $12.50M for the period.
Compared to prior guidance, Trinity Biotech lowered its revenue forecast from a prior range of $15.50M - $16.00M.
Trinity Biotech has issued 4 guidance updates between November 3, 2022 and March 10, 2026. During this period, the company raised its outlook 1 time and lowered it 2 times, providing investors with insight into management's evolving expectations.
Latest Guidance Date
Mar 10, 2026
Guidance Period
Q4 2025
Revenue Guidance Range
$11.50M - $12.50M
Trinity Biotech Guidance History
Review all historical guidance issued by Trinity Biotech, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for Trinity Biotech (TRIB)?
The most recent guidance for Trinity Biotech (TRIB) was reported on March 10, 2026 for Q4 2025. Trinity Biotech forecasted revenue between $11.50M and $12.50M for the period.
What revenue range did Trinity Biotech (TRIB) guide for?
Trinity Biotech (TRIB) guided revenue in the range of $11.50M to $12.50M for Q4 2025.
Did Trinity Biotech (TRIB) raise or lower guidance?
Trinity Biotech (TRIB) lowered its revenue guidance from a prior range of $15.50M - $16.00M to $11.50M - $12.50M for Q4 2025.
When did Trinity Biotech (TRIB) last issue guidance?
Trinity Biotech (TRIB) last issued guidance on March 10, 2026 for Q4 2025.
